CTA-Sticky-button.png clinicaltrialsyearbook+button

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


2016 Highlights

Discussed on this year’s programme were some of the foremost challenges and concerns for clinical trial supply professionals based in the Nordic region.

Day 1 opened with an in-depth look at new strategies for improving efficiency in clinical distribution practice. Highlights from this section included Eva-Lotta Persson’s (Supply Chain Programme Manager, ASTRAZENECA) presentation on how scientific data and risk-based distribution strategy can lower the risk of temperature excursions to avoid wasted product within the clinical supply chain. GS1 Denmark also gave an informative talk on how to apply GS1 standards to the clinical supply chain to enable true visibility across your clinical supply processes. The morning’s discussions were rounded off by an inside look at typical findings and observations in GMP audits by the Danish Medicines Agency.

Day 2 brought more interesting issues to the table with a focus on simplifying label generation. Novo Nordisk and AstraZeneca gave insights into different models for label generation, how to remain regulatory-compliant while simplifying labels and strategies for continuous improvement in this area. After the morning break, Philip Vaering (QA Chemist, ALK-ABELLO), explored how to maintain data integrity and audit of data review during development. The conference closed with three stimulating roundtable discussions on topics ranging from  clinical trial supply from a small company perspective to exploring new GDP regulations and the impact of EU 536/2015 on clinical supply processes.

The quality of the speakers and their presentations at the 2016 event ensured that it was an insightful two days for everyone involved.

Countdown to Clinical Trial Supply Nordics 2018